Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

CRESO PHARMA LIMITED

INVESTOR PRESENTATION - CRESO PHARMA LIMITED

ASX:CPH

CRESO PHARMA LIMITED

Health Care

Creso Pharma Limited (CPH) aims to develop register, and commercialize pharmaceutical-grade cannabis- and hemp-based products and treatments, to the highest GMP quality standards. Company's strategy is to leverage science and research to develop, register and commercialize new cannabis and hemp-derived therapeutic products based on solid scientific data. Company provide safe high grade CBD therapeutic products which are unique in composition, standardized in formulation and dose, and administered by proprietary delivery technologies which fulfill the necessary requirements for efficacy, safety, highest quality and consistency.

Read more

Market Cap

19.28m

Price at Close

$0.028

4w avg. Volume

15.00m

4w avg. Turnover

$466.85k

Announcements
announcementt+2 movementdate
  • Third Purchase Order from Nova Scotia Liquor Corporation

    Progress Report

  • -

    26 Oct 2020

-

26 Oct 2020
  • Ceasing to be a substantial holder

    Shareholder Details

  • -3.23%

    13 Oct 2020

-3.23%

13 Oct 2020
  • Israeli Market Update

    Progress Report

  • -3.23%

    13 Oct 2020

-3.23%

13 Oct 2020
  • Ceasing to be a substantial holder

    Shareholder Details

  • -3.23%

    13 Oct 2020

-3.23%

13 Oct 2020
  • Cleansing Prospectus

    Issued Capital · Market sensitive

  • -11.76%

    12 Oct 2020

-11.76%

12 Oct 2020
  • Secured Debt Update

    Issued Capital

  • -11.76%

    12 Oct 2020

-11.76%

12 Oct 2020
  • Change of Director's Interest Notice x 2

    Shareholder Details

  • -11.76%

    12 Oct 2020

-11.76%

12 Oct 2020
  • Appendix 2A

    Issued Capital

  • -11.76%

    12 Oct 2020

-11.76%

12 Oct 2020
  • Change in substantial holding

    Shareholder Details

  • -11.76%

    12 Oct 2020

-11.76%

12 Oct 2020
  • Second Purchase Order from Pharma Dynamics, South Africa

    Progress Report · Market sensitive

  • -11.76%

    11 Oct 2020

-11.76%

11 Oct 2020
Market Data

Current Price

$0.028

52WK HIGH

$0.24

52WK LOW

$0.028

1YR RETURN

-88.33%

1YR RETURN VS. SECTOR

-101.74%

90 DAY RETURN

-6.67%

ASX RANK

1,463

/2,015

SECTOR RANK

25

/31

SHARES OUTSTANDING

688.42m
ASX:CPH

CRESO PHARMA LIMITED

Health Care

Creso Pharma Limited (CPH) aims to develop register, and commercialize pharmaceutical-grade cannabis- and hemp-based products and treatments, to the highest GMP quality standards. Company's strategy is to leverage science and research to develop, register and commercialize new cannabis and hemp-derived therapeutic products based on solid scientific data. Company provide safe high grade CBD therapeutic products which are unique in composition, standardized in formulation and dose, and administered by proprietary delivery technologies which fulfill the necessary requirements for efficacy, safety, highest quality and consistency.

Read more

Market Cap

19.28m

Price at Close

$0.028

4w avg. Volume

15.00m

4w avg. Turnover

$466.85k

ASX:CPH is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.